CDH2 and cancer: Peptides, in particular, have stimulated the design of small molecule mimetics [49,50], including pioneering work to identify antagonists and agonists of N-cadherin mediated adhesion [51,52], which may be of clinical utility in inhibiting cancer growth and supporting nerve regrowth after injury, respectively.